| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.95 | 0.002 | 0.968 | Psychostimulant | 0.968 0.002 DBMET02029 | DBMET02029 | |
| 0.938 | 0.003 | 0.938 | Tubulin antagonist | 0.925 0.003 DBMET02029 | ||
| 0.808 | 0.004 | 0.808 | Antimitotic | 0.803 0.004 DBMET02029 | ||
| 0.686 | 0.001 | 0.686 | Antineoplastic alkaloid | 0.686 0.001 DBMET02029 | ||
| 0.57 | 0.009 | 0.57 | Hypoxia-inducible factor 1 alpha inhibitor | 0.486 0.016 DBMET02029 | ||
| 0.485 | 0.004 | 0.485 | Beta tubulin antagonist | 0.419 0.004 DBMET02029 | ||
| 0.491 | 0.024 | 0.63 | Spasmolytic | 0.63 0.01 DBMET02029 | DBMET02029 | |
| 0.473 | 0.01 | 0.473 | P-glycoprotein inhibitor | 0.453 0.011 DBMET02029 | ||
| 0.462 | 0.004 | 0.462 | Alpha tubulin antagonist | 0.349 0.004 DBMET02029 | ||
| 0.42 | 0 | 0.42 | Microtubule formation inhibitor | 0.385 0.001 DBMET02029 | ||
| 0.258 | 0.031 | 0.297 | Lipocortins synthesis antagonist | 0.297 0.022 DBMET02029 | DBMET02029 | |
| 0.356 | 0.136 | 0.356 | Apoptosis agonist | 0.303 0.17 DBMET02029 | ||
| 0.227 | 0.036 | 0.227 | Cholinergic | 0.227 0.035 DBMET02029 | ||
| 0.189 | 0.012 | 0.189 | Folate antagonist | 0.181 0.014 DBMET02029 | ||
| 0.286 | 0.124 | 0.305 | Immunosuppressant | 0.305 0.112 DBMET02029 | DBMET02029 | |
| 0.146 | 0.066 | 0.15 | MAP3K9 inhibitor | 0.15 0.06 DBMET02029 | DBMET02029 | |
| 0.146 | 0.079 | 0.153 | Insulin secretagoues | 0.153 0.071 DBMET02029 | DBMET02029 | |
| 0.1 | 0.045 | 0.113 | Acetylcholine M3 receptor agonist | 0.113 0.038 DBMET02029 | DBMET02029 | |
| 0.142 | 0.103 | 0.142 | Nitric oxide antagonist | 0.129 0.12 DBMET02029 | ||
| 0.111 | 0.083 | 0.203 | Cholinergic antagonist | 0.203 0.031 DBMET02029 | DBMET02029 | |
| 0.109 | 0.081 | 0.2 | Acetylcholine antagonist | 0.2 0.031 DBMET02029 | DBMET02029 | |
| 0.061 | 0.033 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 DBMET02029 | DBMET02029 | |
| 0.08 | 0.057 | 0.08 | Antineoplastic antibiotic | 0.076 0.06 DBMET02029 | ||
| 0.054 | 0.037 | 0.059 | Acetylcholine M2 receptor agonist | 0.059 0.03 DBMET02029 | DBMET02029 | |
| 0.074 | 0.062 | 0.103 | Acetylcholine nicotinic antagonist | 0.103 0.037 DBMET02029 | DBMET02029 | |
| 0.087 | 0.082 | 0.087 | Topoisomerase I inhibitor | 0.085 0.084 DBMET02029 | ||
| 0.117 | 0.119 | 0.132 | Sigma receptor agonist | 0.132 0.1 DBMET02029 | DBMET02029 | |
| 0.047 | 0.066 | 0.067 | Adrenaline uptake inhibitor | 0.067 0.038 DBMET02029 | DBMET02029 | |
| 0.06 | 0.1 | 0.074 | Opioid kappa receptor antagonist | 0.074 0.069 DBMET02029 | DBMET02029 | |
| 0.049 | 0.091 | 0.07 | Acetylcholine M4 receptor antagonist | 0.07 0.058 DBMET02029 | DBMET02029 | |
| 0.029 | 0.073 | 0.042 | Dopamine transporter inhibitor | 0.042 0.041 DBMET02029 | DBMET02029 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |